Zocitab: Advanced Relief for Major Depressive Disorder
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $20.16 | $201.59 (0%) | 🛒 Add to cart |
| 20 | $17.40 | $403.18 $348.02 (14%) | 🛒 Add to cart |
| 30 | $16.52 | $604.78 $495.45 (18%) | 🛒 Add to cart |
| 40 | $16.07 | $806.37 $642.89 (20%) | 🛒 Add to cart |
| 50 | $15.81
Best per pill | $1007.96 $790.32 (22%) | 🛒 Add to cart |
Synonyms | |||
Zocitab is a prescription medication formulated with sertraline hydrochloride, a selective serotonin reuptake inhibitor (SSRI) designed for the management of major depressive disorder (MDD) in adults. Clinically proven to restore serotonin balance, Zocitab offers a targeted therapeutic approach to alleviate depressive symptoms, improve mood, and enhance daily functioning. Its well-established efficacy and safety profile make it a first-line option in psychiatric treatment protocols, supporting long-term mental wellness under professional supervision.
Features
- Active ingredient: Sertraline Hydrochloride
- Available in 25 mg, 50 mg, and 100 mg film-coated tablets
- Bioequivalent to reference listed drug
- Manufactured under cGMP standards
- Once-daily oral administration
- Delayed-release formulation for consistent serum levels
Benefits
- Effectively reduces symptoms of depression, including low mood and loss of interest
- Helps restore emotional balance and improves overall quality of life
- Supports better sleep patterns and daily energy levels
- Minimizes anxiety often associated with depressive disorders
- Encourages social and occupational engagement
- Provides a favorable tolerability profile for long-term use
Common use
Zocitab is primarily indicated for the treatment of major depressive disorder (MDD) in adults. It may also be prescribed off-label for other conditions such as obsessive-compulsive disorder (OCD), panic disorder, post-traumatic stress disorder (PTSD), and social anxiety disorder, based on clinical judgment and patient-specific factors.
Dosage and direction
The recommended starting dose for Zocitab is 50 mg administered orally once daily, with or without food. Dosage may be adjusted based on therapeutic response and tolerability, in increments of 50 mg at intervals of no less than one week. The maximum recommended dose is 200 mg per day. It may take several weeks for full therapeutic effects to become apparent. Do not crush, chew, or break the tablet; swallow whole with water.
Precautions
- Monitor for emergence of anxiety, panic attacks, insomnia, irritability, hostility, impulsivity, and suicidality, especially during initial treatment and dose adjustments.
- Use with caution in patients with a history of seizures.
- Screen patients for bipolar disorder prior to initiation; Zocitab is not approved for treating bipolar depression.
- Discontinuation symptoms may occur; taper dose gradually under medical supervision.
- advise patients to avoid alcohol during treatment.
Contraindications
- Hypersensitivity to sertraline or any component of the formulation.
- Concurrent use with monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOI therapy.
- Use of pimozide.
- Uncontrolled narrow-angle glaucoma.
Possible side effects
Common side effects may include nausea, diarrhea, insomnia, dizziness, dry mouth, fatigue, increased sweating, and sexual dysfunction. Less frequently, patients may experience tremors, palpitations, weight changes, or blurred vision. Serious side effects such as serotonin syndrome, abnormal bleeding, hyponatremia, or manic episodes are rare but require immediate medical attention.
Drug interaction
Zocitab may interact with:
- MAOIs (risk of serotonin syndrome)
- Other serotonergic drugs (e.g., tramadol, triptans)
- NSAIDs, aspirin, or warfarin (increased bleeding risk)
- Drugs metabolized by CYP2D6 (e.g., tricyclic antidepressants, antipsychotics)
- Drugs that prolong QT interval
- inform your healthcare provider of all medications, including over-the-counter drugs and supplements.
Missed dose
If a dose is missed, take it as soon as remembered unless it is almost time for the next dose. Do not double the dose to make up for the missed one. Resume the regular dosing schedule.
Overdose
Symptoms of overdose may include serotonin syndrome, dizziness, agitation, nausea, vomiting, tachycardia, and seizures. In case of suspected overdose, seek immediate medical attention or contact a poison control center. Provide supportive care; there is no specific antidote.
Storage
Store at room temperature (20°–25°C or 68°–77°F), in a dry place, away from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes and does not replace professional medical advice. Always consult a qualified healthcare provider for diagnosis, treatment decisions, and personalized medical guidance. Do not initiate or discontinue Zocitab without medical supervision.
Reviews
“After six weeks on Zocitab, my depressive symptoms have significantly improved. I feel more engaged and functional.” – Patient, 42
“Effective for MDD with manageable side effects. Prefer it for its consistent performance in clinical practice.” – Psychiatrist, 15 years experience
“Noticed gradual but sustained mood improvement. Some initial nausea, but it subsided.” – Patient, 35